Vascular Endothelial Growth Factors and Receptors: Signaling in Vascular Development

Handbook of Cell Signaling, Second Edition

Volumn 2, Issue , 2009, Pages 1927-1937

  Dimberg, Anna ^a   Rolny, Charlotte ^a   van Meeteren, Laurens A ^a   Claesson Welsh, Lena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882838635     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374145-5.00236-9     Document Type: Chapter

References (98)

1. YA Muller, HW Christinger, BA Keyt and AM de Vos (1997) The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93A resolution: multiple copy flexibility and receptor binding. Structure 5 1325-1338.
2. D Shweiki, A Itin, D Soffer and E Keshet (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 843-845.
3. H Takahashi and M Shibuya (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 109 227-241.
4. K Suto, Y Yamazaki, T Morita and H Mizuno (2005) Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J Biol Chem 280 2126-2131.
5. W Wood, C Faria and A Jacinto (2006) Distinct mechanisms regulate hemocyte chemotaxis during development and wound healing in Drosophila melanogaster. J Cell Biol 173 405-416.
6. C Ruch, G Skiniotis, MO Steinmetz, T Walz and K Ballmer-Hofer (2007) Structure of a VEGF-VEGF receptor complex determined by electron microscopy. Nat Struct Mol Biol 14 249-250.
7. J Dixelius, T Makinen, M Wirzenius, MJ Karkkainen, C Wernstedt, K Alitalo and L Claesson-Welsh (2003) Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem 278 40,973-40,979.
8. K Huang, C Andersson, GM Roomans, N Ito and L Claesson-Welsh (2001) Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. Intl J Biochem Cell Biol 33 315-324.
9. Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 2008. in press.
10. S Zacchigna, C Ruiz de Almodovar and P Carmeliet (2008) Similarities between angiogenesis and neural development: what small animal models can tell us. Curr Topics Dev Biol 80 1-55.
11. A Schmidt, K Brixius and W Bloch (2007) Endothelial precursor cell migration during vasculogenesis. Circ Res 101 125-136.
12. F Bertolini, Y Shaked, P Mancuso and RS Kerbel (2006) The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 6 835-845.
13. H Gerhardt, M Golding, M Fruttiger, C Ruhrberg, A Lundkvist, A Abramsson, M Jeltsch, C Mitchell, K Alitalo, D Shima and C Betsholtz (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161 1163-1177.
14. AF Siekmann, L Covassin and ND Lawson (2008) Modulation of VEGF signalling output by the Notch pathway. Bioessays 30 303-313.
15. PH Burri, R Hlushchuk and V Djonov (2004) Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn 231 474-488.
16. AC Schuh, P Faloon, QL Hu, M Bhimani and K Choi (1999) In vitro hematopoietic and endothelial potential of flk-1(−/−) embryonic stem cells and embryos. Proc Natl Acad Sci USA 96 2159-2164.
17. X Li, D Edholm, F Lanner, G Breier, F Farnebo, A Dimberg and L Claesson-Welsh (2007) Lentiviral rescue of vascular endothelial growth factor receptor-2 expression in flk1−/− embryonic stem cells shows early priming of endothelial precursors. Stem Cells 25 2987-2995.
18. F Shalaby, J Rossant, TP Yamaguchi, M Gertsenstein, XF Wu, ML Breitman and AC Schuh (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 62-66.
19. P Carmeliet, V Ferreira, G Breier, S Pollefeyt, L Kieckens, M Gertsenstein, M Fahrig, A Vandenhoeck, K Harpal, C Eberhardt, C Declercq, J Pawling, L Moons, D Collen, W Risau and A Nagy (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 435-439.
20. RK Jain, DG Duda, JW Clark and JS Loeffler (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3 24-40.
21. N Ferrara, K Carver-Moore, H Chen, M Dowd, L Lu, KS O’Shea, L Powell-Braxton, KJ Hillan and MW Moore (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 439-442.
22. I Stalmans, YS Ng, R Rohan, M Fruttiger, A Bouche, A Yuce, H Fujisawa, B Hermans, M Shani, S Jansen, D Hicklin, DJ Anderson, T Gardiner, HP Hammes, L Moons, M Dewerchin, D Collen, P Carmeliet and PA D’Amore (2002) Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 109 327-336.
23. P Carmeliet, YS Ng, D Nuyens, G Theilmeier, K Brusselmans, I Cornelissen, E Ehler, VV Kakkar, I Stalmans, V Mattot, JC Perriard, M Dewerchin, W Flameng, A Nagy, F Lupu, L Moons, D Collen, PA D’Amore and DT Shima (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5 495-502.
24. E Zelzer, W McLean, YS Ng, N Fukai, AM Reginato, S Lovejoy, PA D’Amore and BR Olsen (2002) Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129 1893-1904.
25. C Maes, P Carmeliet, K Moermans, I Stockmans, N Smets, D Collen, R Bouillon and G Carmeliet (2002) Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111 61-73.
26. C Maes, I Stockmans, K Moermans, R Van Looveren, N Smets, P Carmeliet, R Bouillon and G Carmeliet (2004) Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 113 188-199.
27. M Dougher and BI Terman (1999) Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization. Oncogene 18 1619-1627.
28. LW Wu, LD Mayo, JD Dunbar, KM Kessler, ON Ozes, RS Warren and DB Donner (2000) VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor. J Biol Chem 275 6059-6062.
29. T Matsumoto, S Bohman, J Dixelius, T Berge, A Dimberg, P Magnusson, L Wang, C Wikner, JH Qi, C Wernstedt, J Wu, S Bruheim, H Mugishima, D Mukhopadhyay, A Spurkland and L Claesson-Welsh (2005) VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J 24 2342-2353.
30. BP Eliceiri, R Paul, PL Schwartzberg, JD Hood, J Leng and DA Cheresh (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4 915-924.
31. S Weis, S Shintani, A Weber, R Kirchmair, M Wood, A Cravens, H McSharry, A Iwakura, YS Yoon, N Himes, D Burstein, J Doukas, R Soll, D Losordo and D Cheresh (2004) Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113 885-894.
32. T Takahashi, S Yamaguchi, K Chida and M Shibuya (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 20 2768-2778.
33. T Takahashi, H Ueno and M Shibuya (1999) VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18 2221-2231.
34. Y Sakurai, K Ohgimoto, Y Kataoka, N Yoshida and M Shibuya (2005) Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci USA 102 1076-1081.
35. K Holmqvist, MJ Cross, C Rolny, R Hagerkvist, N Rahimi, T Matsumoto, L Claesson-Welsh and M Welsh (2004) The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279 22,267-22,275.
36. AJ Warner, J Lopez-Dee, EL Knight, JR Feramisco and SA Prigent (2000) The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells. Biochem J 347 501-509.
37. HJ Liao, T Kume, C McKay, MJ Xu, JN Ihle and G Carpenter (2002) Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. J Biol Chem 277 9335-9341.
38. ND Lawson, JW Mugford, BA Diamond and BM Weinstein (2003) phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development. Genes Dev 17 1346-1351.
39. M Graupera, J Guillermet-Guibert, LC Foukas, LK Phng, RJ Cain, A Salpekar, W Pearce, S Meek, J Millan, PR Cutillas, AJ Smith, AJ Ridley, C Ruhrberg, H Gerhardt and B Vanhaesebroeck (2008) Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature 453 662-666.
40. Y Fujio and K Walsh (1999) Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 274 16,349-16,354.
41. S Dimmeler, I Fleming, B Fisslthaler, C Hermann, R Busse and AM Zeiher (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 601-605.
42. D Fulton, JP Gratton, TJ McCabe, J Fontana, Y Fujio, K Walsh, TF Franke, A Papapetropoulos and WC Sessa (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 597-601.
43. J Chen, PR Somanath, O Razorenova, WS Chen, N Hay, P Bornstein and TV Byzova (2005) Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med 11 1188-1196.
44. CC Hong, QP Peterson, JY Hong and RT Peterson (2006) Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol 16 1366-1372.
45. RE Lamont and S Childs (2006) MAPping out arteries and veins. Sci STKE 2006 pe39.
46. BM Weinstein and ND Lawson (2002) Arteries, veins, Notch, and VEGF. Cold Spring Harb Symp Quant Biol 67 155-162.
47. L Lamalice, F Houle, G Jourdan and J Huot (2004) Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 23 434-435.
48. ME McMullen, PW Bryant, CC Glembotski, PA Vincent and KM Pumiglia (2005) Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J Biol Chem 280 20,995-21,003.
49. S Rousseau, F Houle, J Landry and J Huot (1997) p 38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15 2169-2177.
50. H Habeck, J Odenthal, B Walderich, H Maischein and S Schulte-Merker (2002) Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Curr Biol 12 1405-1412.
51. N Bahary, K Goishi, C Stuckenholz, G Weber, J Leblanc, CA Schafer, SS Berman, M Klagsbrun and LI Zon (2007) Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish. Blood 110 3627-3636.
52. K Bruckner, L Kockel, P Duchek, CM Luque, P Rorth and N Perrimon (2004) The PDGF/VEGF receptor controls blood cell survival in Drosophila. Dev Cell 7 73-84.
53. S Maynard, FH Epstein and SA Karumanchi (2008) Preeclampsia and angiogenic imbalance. Annu Rev Med 59 61-78.
54. G Girardi, R Bulla, JE Salmon and F Tedesco (2006) The complement system in the pathophysiology of pregnancy. Mol Immunol 43 68-77.
55. AK Olsson, A Dimberg, J Kreuger and L Claesson-Welsh (2006) VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 7 359-371.
56. N Ito, C Wernstedt, U Engstrom and L Claesson-Welsh (1998) Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. J Biol Chem 273 23,410-23,418.
57. GH Fong, J Rossant, M Gertsenstein and ML Breitman (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 66-70.
58. JB Kearney, CA Ambler, KA Monaco, N Johnson, RG Rapoport and VL Bautch (2002) Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood 99 2397-2407.
59. S Hiratsuka, K Nakao, K Nakamura, M Katsuki, Y Maru and M Shibuya (2005) Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol Cell Biol 25 346-354.
60. S Hiratsuka, O Minowa, J Kuno, T Noda and M Shibuya (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95 9349-9354.
61. D Lyden, K Hattori, S Dias, C Costa, P Blaikie, L Butros, A Chadburn, B Heissig, W Marks, L Witte, Y Wu, D Hicklin, Z Zhu, NR Hackett, RG Crystal, MA Moore, KA Hajjar, K Manova, R Benezra and S Rafii (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7 1194-1201.
62. A Luttun, M Tjwa, L Moons, Y Wu, A Angelillo-Scherrer, F Liao, JA Nagy, A Hooper, J Priller, B De Klerck, V Compernolle, E Daci, P Bohlen, M Dewerchin, JM Herbert, R Fava, P Matthys, G Carmeliet, D Collen, HF Dvorak, DJ Hicklin and P Carmeliet (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8 831-840.
63. M Autiero, J Waltenberger, D Communi, A Kranz, L Moons, D Lambrechts, J Kroll, S Plaisance, M De Mol, F Bono, S Kliche, G Fellbrich, K Ballmer-Hofer, D Maglione, U Mayr-Beyrle, M Dewerchin, S Dombrowski, D Stanimirovic, P Van Hummelen, C Dehio, DJ Hicklin, G Persico, JM Herbert, M Shibuya, D Collen, EM Conway and P Carmeliet (2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9 936-943.
64. P Carmeliet, L Moons, A Luttun, V Vincenti, V Compernolle, M De Mol, Y Wu, F Bono, L Devy, H Beck, D Scholz, T Acker, T DiPalma, M Dewerchin, A Noel, I Stalmans, A Barra, S Blacher, T Vandendriessche, A Ponten, U Eriksson, KH Plate, JM Foidart, W Schaper, DS Charnock-Jones, DJ Hicklin, JM Herbert, D Collen and MG Persico (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7 575-583.
65. K Aase, G von Euler, X Li, A Ponten, P Thoren, R Cao, Y Cao, B Olofsson, S Gebre-Medhin, M Pekny, K Alitalo, C Betsholtz and U Eriksson (2001) Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect. Circulation 104 358-364.
66. P Saharinen, T Tammela, MJ Karkkainen and K Alitalo (2004) Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25 387-395.
67. T Tammela, TV Petrova and K Alitalo (2005) Molecular lymphangiogenesis: new players. Trends Cell Biol 15 434-441.
68. DJ Dumont, L Jussila, J Taipale, A Lymboussaki, T Mustonen, K Pajusola, M Breitman and K Alitalo (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282 946-949.
69. MJ Karkkainen, P Haiko, K Sainio, J Partanen, J Taipale, TV Petrova, M Jeltsch, DG Jackson, M Talikka, H Rauvala, C Betsholtz and K Alitalo (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5 74-80.
70. AM Kuchler, E Gjini, J Peterson-Maduro, B Cancilla, H Wolburg and S Schulte-Merker (2006) Development of the zebrafish lymphatic system requires VEGFC signaling. Curr Biol 16 1244-1248.
71. ME Baldwin, MM Halford, S Roufail, RA Williams, ML Hibbs, D Grail, H Kubo, SA Stacker and MG Achen (2005) Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol 25 2441-2449.
72. M Song, H Yang, S Yao, F Ma, Z Li, Y Deng, H Deng, Q Zhou, S Lin and Y Wei (2007) A critical role of vascular endothelial growth factor D in zebrafish embryonic vasculogenesis and angiogenesis. Biochem Biophys Res Commun 357 924-930.
73. Ny A, Koch M, Vandevelde W, Schneider M, Fischer C, Diez-Juan A, Neven E, Geudens I, Maity S, Moons L, Plaisance S, Lambrechts D, Carmeliet P, Dewerchin M. Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Blood 2008.
74. A Irrthum, MJ Karkkainen, K Devriendt, K Alitalo and M Vikkula (2000) Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67 295-301.
75. JD Esko and SB Selleck (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71 435-471.
76. AM Dougher, H Wasserstrom, L Torley, L Shridaran, P Westdock, RE Hileman, JR Fromm, R Anderberg, S Lyman, RJ Linhardt, J Kaplan and BI Terman (1997) Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors 14 257-268.
77. L Jakobsson, J Kreuger, K Holmborn, L Lundin, I Eriksson, L Kjellen and L Claesson-Welsh (2006) Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell 10 625-634.
78. H Fujisawa, T Kitsukawa, A Kawakami, S Takagi, M Shimizu and T Hirata (1997) Roles of a neuronal cell-surface molecule, neuropilin, in nerve fiber fasciculation and guidance. Cell Tissue Res 290 465-470.
79. AL Kolodkin, DV Levengood, EG Rowe, YT Tai, RJ Giger and DD Ginty (1997) Neuropilin is a semaphorin III receptor. Cell 90 753-762.
80. Z He and M Tessier-Lavigne (1997) Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90 739-751.
81. S Soker, S Takashima, HQ Miao, G Neufeld and M Klagsbrun (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 735-745.
82. Y Shintani, S Takashima, Y Asano, H Kato, Y Liao, S Yamazaki, O Tsukamoto, O Seguchi, H Yamamoto, T Fukushima, K Sugahara, M Kitakaze and M Hori (2006) Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. Embo J 25 3045-3055.
83. T Karpanen, CA Heckman, S Keskitalo, M Jeltsch, H Ollila, G Neufeld, L Tamagnone and K Alitalo (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20 1462-1472.
84. T Kawasaki, T Kitsukawa, Y Bekku, Y Matsuda, M Sanbo, T Yagi and H Fujisawa (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126 4895-4902.
85. T Kitsukawa, M Shimizu, M Sanbo, T Hirata, M Taniguchi, Y Bekku, T Yagi and H Fujisawa (1997) Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19 995-1005.
86. T Kitsukawa, A Shimono, A Kawakami, H Kondoh and H Fujisawa (1995) Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121 4309-4318.
87. RJ Giger, JF Cloutier, A Sahay, RK Prinjha, DV Levengood, SE Moore, S Pickering, D Simmons, S Rastan, FS Walsh, AL Kolodkin, DD Ginty and M Geppert (2000) Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 25 29-41.
88. H Chen, A Bagri, JA Zupicich, Y Zou, E Stoeckli, SJ Pleasure, DH Lowenstein, WC Skarnes, A Chedotal and M Tessier-Lavigne (2000) Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 25 43-56.
89. L Yuan, D Moyon, L Pardanaud, C Breant, MJ Karkkainen, K Alitalo and A Eichmann (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129 4797-4806.
90. S Takashima, M Kitakaze, M Asakura, H Asanuma, S Sanada, F Tashiro, H Niwa, J Miyazaki Ji, S Hirota, Y Kitamura, T Kitsukawa, H Fujisawa, M Klagsbrun and M Hori (2002) Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 99 3657-3662.
91. C Gu, ER Rodriguez, DV Reimert, T Shu, B Fritzsch, LJ Richards, AL Kolodkin and DD Ginty (2003) Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 5 45-57.
92. HH Yu, C Houart and CB Moens (2004) Cloning and embryonic expression of zebrafish neuropilin genes. Gene Expr Patterns 4 371-378.
93. P Lee, K Goishi, AJ Davidson, R Mannix, L Zon and M Klagsbrun (2002) Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci USA 99 10,470-10,475.
94. C Weber, L Fraemohs and E Dejana (2007) The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 7 467-477.
95. P Carmeliet, MG Lampugnani, L Moons, F Breviario, V Compernolle, F Bono, G Balconi, R Spagnuolo, B Oostuyse, M Dewerchin, A Zanetti, A Angellilo, V Mattot, D Nuyens, E Lutgens, F Clotman, MC de Ruiter, A Gittenberger-de Groot, R Poelmann, F Lupu, JM Herbert, D Collen and E Dejana (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 147-157.
96. D Bellomo, JP Headrick, GU Silins, CA Paterson, PS Thomas, M Gartside, A Mould, MM Cahill, ID Tonks, SM Grimmond, S Townson, C Wells, M Little, MC Cummings, NK Hayward and GF Kay (2000) Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 86 E29-E35.
97. GH Fong, L Zhang, DM Bryce and J Peng (1999) Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126 3015-3025.
98. S Hiratsuka, Y Maru, A Okada, M Seiki, T Noda and M Shibuya (2001) Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res 61 1207-1213.